We first analyzed RNAseq data from AML-patient data from the Leucegene database due to its known prevalence of WT1 expression and high depth of sequencing, which facilitates the identification of splice variants using an alignment-free Kmer approach [65, 66]. The gene discussed is WT1; the disease is acute myeloid leukemia.